The ability of RUNX2 to enhance the metastatic potential of tumor cells is largely based on its ability to regulate genes crucial to tumor progression including VEGF, MMP9, MMP13, OPN, SNAI 1–2, TWIST1 and TIMP13 [3, 6, 23–29]. The gene discussed is MMP9; the disease is neoplasm.